Biosimilar Antibodies
| Cat.No. | Product Name | Information | Isotype |
|---|---|---|---|
| A3128 | Anti-Spike RBD Antibody (P16-A3) | Anti-Spike RBD Antibody (P16-A3) is an antibody specifically targeting and binding to coronavirus S protein. It showed excellent and significantly better activity in coronaviruses diseases. MW :150 KD. | Human IgG1 |
| A2617 | Rosopatamab (Anti-FOLH1 / PSMA) | Rosopatamab (Anti-FOLH1 / PSMA) is a humanised monoclonal antibody targeting PSMA. It can be used in cancer research, particularly in prostate cancer. MW: 144.36. | Human IgG1 |
| A2873 | Anti-ICAM3 / CD50 | Anti-ICAM3 / CD50 is an IgG1 monoclonal antibody against intercellular adhesion molecules-3 (ICAM-3, also known as CD50)) with the potential to have anti-proliferative activities. MW: 145.22 KD. | Human IgG1 |
| A2618 | Anti-Siglec-15 / CD33L3 (NC318) | Anti-Siglec-15 / CD33L3 (NC318) is a monoclonal antibody targeting Siglec-15. It can be used as a novel immune suppressor and a potential target for normalization cancer immunotherapy. MW :146.98 KD. | Human IgG1 |
| A2874 | Anti-MUC17 | Anti-MUC17 is an IgG1 monoclonal antibody against MUC17, a membrane-bound protein highly expressed on the surface of intestinal cells. MW: 146.66 KD. | Human IgG1 |
| A2619 | Lirentelimab (Anti-Siglec-8) | Lirentelimab (Anti-Siglec-8) is a humanised IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). It can be used for the research of eosinophilic gastritis and duodenitis. MW :150 KD. | Human IgG1 |
| A3131 | Anti-Nucleocapsid Antibody (N-9) | Anti-Nucleocapsid Antibody (N-9) targets the nucleocapsid protein of coronavirus. It promotes IL-6 production in SARS-CoV-2-infected alveoli. It is used in acute respiratory distress syndrome MW: 150 KD. | Human IgG1 |
| A2620 | Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) | Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) is a fully human IgG2 monoclonal antibody targeting the T-cell costimulatory receptor 4-1BB/CD137. It can be used for the research of relapsed/refractory follicular lymphoma (FL), non-Hodgkin lymphomas (NHL). MW :142.78. | Human IgG2SA |
| A2876 | Frovocimab (Anti-PCSK9) | Frovocimab (Anti-PCSK9) is a humanised IgG4 monoclonal antibody that neutralises proprotein convertase subtilisin-kexin type 9 (PCSK9). MW: 146.88 KD. | Human IgG4SP |
| A3132 | Anti-Nucleocapsid Antibody (N-18) | Anti-Nucleocapsid Antibody (N-18) is an antibody targeting the nucleocapsid protein of coronavirus. It is used in diagnosis with significantly associated with faster symptom resolution for COVID-19 patients. MW :150 KD. | Human IgG1 |
| A2621 | Anti-ACVR1 / ALK-2 (DS-6016a) | Anti-ACVR1 / ALK-2 (DS-6016a) monoclonal antibody targeting ALK-2. It can be used in the treatment of fibrodysplasia ossificans progressiva (FOP). MW :145.56. | Human IgG1 |
| A2622 | Anti-ACVR2A (Ab-14E1) | Anti-ACVR2A (Ab-14E1) is a rabbit polyclonal antibody targeting human ACVR2A. It can be used in research of human intestinal cancer and preeclampsia. MW: 146.36 KD. | Human IgG1 |
| A2878 | Gancotamab (Anti-ERBB2 / HER2 / CD340) | Gancotamab (Anti-ERBB2 / HER2 / CD340) is a HER2-targeted PEGylated liposome that encapsulates doxorubicin to facilitate its delivery to HER2-overexpressing tumour cells. MW: 143.6 KD. | Human IgG1 |
| A2623 | Prasinezumab (Anti-Alpha-synuclein) | Prasinezumab (Anti-Alpha-synuclein) is a humanised IgG1 monoclonal antibody targeting aggregated -synuclein. It has the potential for Parkinson's disease research. MW: 150 KD. | Human IgG1 |
| A2879 | Gatipotuzumab (Anti-MUC1) | Gatipotuzumab (Anti-MUC1) is a humanized monoclonal antibody recognising the tumour-specific epitope of mucin-1 (TA-MUC1) with potential antineoplastic activity. MW: 146.58 KD. | Human IgG1 |
| A3135 | Anti-Nucleocapsid Antibody (N-P10) | Anti-Nucleocapsid Antibody (N-P10) is a monoclonal antibody targeting the SARS-CoV-2 nucleocapsid protein (NP). It has strong potential for use in the clinical detection of SARS-CoV-2 infection, whether the virus is wild-type or a variant of concern. MW: 150 KD. | Human IgG1 |
| A2624 | Nesvacumab (Anti-ANGPT2) | Nesvacumab (Anti-ANGPT2) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody that specifically targets the Tie2 receptor ligand Angiopoietin-2 (Ang2). It has potential anti-tumour activity. MW: 150 KD. | Human IgG1 |
| A3136 | Anti-Nucleocapsid Antibody (N-P11) | Anti-Nucleocapsid Antibody (N-P10) is a monoclonal antibody targeting the SARS-CoV-2 nucleocapsid protein (NP). It has strong potential for use in the clinical detection of SARS-CoV-2 infection, whether the virus is wild-type or a variant of concern. MW: 150 KD. | Human IgG1 |
| A2625 | Anti-TNFSF13 / APRIL / CD256 (BION-1301) | Anti-TNFSF13 / APRIL / CD256 (BION-1301) is a humanised antibody targeting a proliferation Inducing Ligand (APRIL, TNFSF13). It can be used in the treatment of IgA nephropathy. MW :150 KD. | Human IgG2SA |
| A3137 | Anti-Spike RBD Antibody (R15-F7) | Anti-Spike RBD Antibody (R15-F7) is a potent human antibody targeting the spike receptor binding domain of SARS-CoV-2. It can be used in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). MW: 145.2 KD. | Human IgG4SP |
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.